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Background
Routine primary care screening for depression and
alcohol use is widely recommended. Benefits of screen-
ing for marijuana and drug use are less clear, but
might identify patients whose drug use complicates
their health. As a result, leaders of a large integrated
healthcare system in a U.S. state, where recreational
marijuana use was recently legalized, implemented
screening for marijuana and drug use as part of a pilot
of behavioral health integration in primary care. The
objective is to describe the prevalence of screening and
further assessment of marijuana and drug use com-
pared to depression and alcohol misuse during early
implementation.
Material and methods
This study included patients who visited the pilot pri-
mary care clinic during the initial 6 weeks of implemen-
tation. A paper-based 7-item behavioral health screen
included the PHQ2 (depression), AUDIT-C (alcohol
misuse), and single-item screens for marijuana and drug
use. Primary care teams were expected to screen all
adults patients annually and further assess positive
screens (PHQ2¿2 either item, AUDIT-C>6, daily mari-
juana use and any drug use) using the PHQ9 (depres-
sion) and the assessment of DSM-5 symptoms for
alcohol or drug use disorders, respectively. We describe
the prevalence of screening, positive screens, and further
assessment for each.
Results
Of 4,332 eligible patients, 76.3% were screened for depres-
sion, compared to 74.7% (alcohol), 74.3% (marijuana), and
74.2% (other drug use). Of those screened, 15%, 1.9%, 2.7%
and 1.0% were positive for depression, moderate-to-severe
alcohol misuse, daily marijuana use and any drug use,
respectively. Rates of further assessment of positive
screens varied widely: 82.4% for depression, 57.4% alcohol,
37.2% marijuana and 21.2% drug.
Conclusions
Among these adult Washington State primary care
patients seen during pilot implementation, any mari-
juana use was fairly common (14.1%). Rates of follow-up
assessment for those with daily marijuana or any other
drug use were lower than for depression and alcohol
misuse.
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